Company Filing History:
Years Active: 2007
Title: The Innovations of Jospeh T Strupczewski
Introduction
Jospeh T Strupczewski is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target dopamine receptors. His work has implications for treating various central nervous system disorders.
Latest Patents
Strupczewski holds a patent related to heterocyclic substituted carbonyl derivatives that exhibit selective binding to dopamine receptors. This invention outlines a method for treating central nervous system disorders associated with dopamine receptor activity. The disorders that may be treated with these compounds include psychotic disorders, substance dependence, substance abuse, dyskinetic disorders such as Parkinson's Disease, dementia, anxiety disorders, sleep disorders, circadian rhythm disorders, and mood disorders. The patent also describes processes for preparing these compounds and their use as imaging agents for dopamine receptors.
Career Highlights
Strupczewski is currently associated with Aventis Pharmaceuticals Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments for complex neurological conditions.
Collaborations
Some of his notable coworkers include James Hendrix and Horst Hemmerle, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Jospeh T Strupczewski's contributions to the field of pharmaceuticals highlight the importance of innovation in treating central nervous system disorders. His work continues to pave the way for new therapeutic approaches that can significantly improve patient outcomes.